Trial intelligence / Profile preview

Efficacy and Safety of Ethinylestradiol/Gestodene Patch (Lisvy) for Contraception

NCT00914693Phase 3Completed

Sponsor
Bayer
Start
Apr 2009
Primary completion
Sep 2011
Modality
Small Molecules
Countries
8
01

Overview

A Phase 3 trial of ethinyl estradiol, gestodene in contraception, sponsored by Bayer. Started Apr 2009; status: completed.

02

Drugs

ethinyl estradiolgestodene
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00914693.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00914693.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call